Results 71 to 80 of about 3,912,192 (199)

Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics. [PDF]

, 2020
Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for regenerative therapy, disease modeling, and drug discovery.
Chandy, Mark, Paik, David T, Wu, Joseph C   +2 more
core  

PENGARUH PEMBERIAN INFORMASI OBAT TERHADAP TINGKAT KEPATUHAN PENGGUNAAN ANTIBIOTIKA PADA PASIEN ISPA DI PUSKESMAS KOTAGEDE I YOGYAKARTA

Pharmaciana, 2014
ARI is an acute respiratory infection requiring antibiotics. The use of antibiotics should be routinely to prevent resistance. The design of this research was experimental by treatment of the cases. How to collect the data used prospective method.
Stefy Muliyani Muljabar, Woro Supadmi
doaj   +1 more source

Patient preferences for the provision of NHS medicines helpline services: a discrete choice experiment

Journal of Pharmaceutical Policy and Practice
Introduction: Patient medicines helpline services (PMHS) can reduce harm and improve medicines adherence and patient satisfaction after hospital discharge. There is little evidence of which PMHS attributes are most important to patients.
Ben Ashby, Matthew D. Jones
doaj   +1 more source

Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. [PDF]

, 2013
Drug-drug interactions (DDI) account for 30% of all adverse drug reactions, which are the fourth leading cause of death in the US. Current methods for post marketing surveillance primarily use spontaneous reporting systems for learning DDI signals and ...
Bauer-Mehren, Anna, Harpaz, Rave, Iyer, Srinivasan V, Lependu, Paea, Shah, Nigam H   +4 more
core   +5 more sources

Demand for Illicit Drugs by Pregnant Women [PDF]

We use survey data that have been linked to medical records data and city-level drug prices to estimate the demand for illicit drugs among pregnant women.
Dhaval Dave, Hope Corman, Kelly Noonan, Nancy E. Reichman   +3 more
core  

Medicare Part D: How Do Vulnerable Beneficiaries Fare? [PDF]

, 2008
Based on a survey of counselors, program managers, and health workers, outlines the need to provide user-friendly information, facilitate enrollment and plan choice, and improve monitoring and counseling for the prescription drug benefit's ...
Jeanne Finberg, Laura Summer, Patricia Nemore   +2 more
core  

A Comparative Study of Drug Package Inserts of High Selling Cardiac Drugs against the Drug Regulations of Iranian Food and Drug Administration [PDF]

Taṣvīr-i salāmat, 2019
Background and Objectives: The Drug Package Insert (PI) is a written information provided by drug manufacturers to deliver essential information for the consumer.
Sedigheh Mirzadeh Qasabeh, Vahideh Zareh Gavgani   +1 more
doaj  

Information and drug prices: evidence from the Medicare discount drug card program [PDF]

In early 2004, the U.S. Government initiated the Medicare Discount Drug Card Program (MDDCP), which created a market for drug cards that allowed elderly and handicapped subscribers to obtain discounts on their prescription drug purchases.
Emin M. Dinlersoz, Han Li, Roger Sherman, Rubén Hernández-Murillo   +3 more
core  

Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities

Clinical and Translational Science
Monoclonal antibodies (mAbs) are critical components in the therapeutic landscape, but their dosing strategies often evolve post‐approval as new data emerge.
Nai Lee, Su‐jin Rhee, Seong Min Koo, So Won Kim, Gyo Eun Lee, Yoon A Yie, Yun Kim   +6 more
doaj   +1 more source

Why Do Some People Want to Legalize Cannabis Use? [PDF]

Preferences and attitudes to illicit drug policy held by individuals are likely to be an important in uence in the development of illicit drug policy.
Grossmann, M., Ours, J.C. van, Williams, J.   +2 more
core   +1 more source